Foghorn Therapeutics Inc. Common Stock vs. Johnson & Johnson
Johnson & Johnson (JNJ) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| FHTX | JNJ | |
|---|---|---|
| Market Cap | $292.18 million | $663.28 billion |
| Revenue (TTM) | $36.74 million | $97.93 billion |
| Net Income (TTM) | $-64,579,000 | $21.04 billion |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| FHTX | JNJ | |
|---|---|---|
| P/E Ratio | — | 31.93 |
| Price / Book | -3.61 | 7.81 |
| Price / Sales | 7.95 | 6.77 |
FHTX and JNJ split the valuation factors evenly.
Profitability
| FHTX | JNJ | |
|---|---|---|
| Net Margin | -175.78% | 21.48% |
| Return on Equity | 79.69% | 24.76% |
FHTX and JNJ split the profitability factors evenly.
Dividend
| FHTX | JNJ | |
|---|---|---|
| Dividend Yield | — | 1.95% |
| Payout Ratio | — | 62.18 |
FHTX and JNJ split the dividend factors evenly.
Risk & Sentiment
| FHTX | JNJ | |
|---|---|---|
| Short Interest | 0.03% | 0.67% |
FHTX leads on 1 of 1 risk & sentiment factors.
Dig deeper: FHTX overview, FHTX financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.